Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

JUNE 16, 2016

Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. To understand the nature of the problem, let’s look at how penicillin was brought to market. a leader in virtually every area of advanced technology. The Valley of Death.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. and technological uncertainty (can we make a desirable solution?) Technological uncertainty results from unknowns regarding the technologies that might emerge or be combined to create a new solution.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

OCTOBER 26, 2011

Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail).

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

APRIL 27, 2012

It's an age of unprecedented, staggering technological change. but the emerging markets boom has generally been more about catching up than exploiting cutting-edge technology.). Even beyond the technological challenges, there are lots of other obstacles to change. Or something like that.

Stephenson 15

Stephenson Innovation Biotechnology eBook 15

Harvard Business Review

NOVEMBER 15, 2016

Despite the East Coast roots of technology entrepreneurship and venture capital (VC), by the 1990s Silicon Valley had gained a major advantage over the Cambridge-Boston area. The same underlying technologies (e.g., Silicon Valley dominates these platform technologies. stood at 22.6%, more than twice New England’s 9.9%

Biotechnology 8

Biotechnology Drucker Software Entrepreneur 8

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). In these markets if existing companies don’t rise to the innovation challenge, no one will.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Strategy Driven

NOVEMBER 18, 2019

This increased the need for care items for the elderly and there are plenty of gaps in the market for the healthcare sector. There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. Technology. Financial sector.

Health Care 67

Health Care Biotechnology Energy Insurance 67

Harvard Business Review

MARCH 8, 2013

Many of the revolutionary technologies that make the iPhone and other products and services "smart" were funded by the U.S. This also stands in stark contrast to the steps that Apple, Google, and other technology companies take to avoid paying taxes. government is often portrayed as providing a safeguard against market failure.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Innovation 8

Harvard Business Review

MAY 10, 2016

After all, if acquisitions pay off they can provide a transformational antidote to a slowing core market and declining margins. Gillette dominated the men’s shaving market with its Mach series of razors.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

MARCH 28, 2012

This means they're buying drugs that could be similar to others already on or coming soon to the market. No company should confuse the strategy of buying into a big market with buying innovation that will bring tomorrow's growth. The technology world has some harrowing examples that no innovation-based industry should ever forget.

Innovation 12

Innovation Company Biotechnology CFO 12

Harvard Business Review

JUNE 12, 2012

Paul Kennedy's seminal Rise and Fall of the Great Powers captures the way technological and economic advances have converted into strategic advantage, and how failure to "lock in" that edge accelerates imperial decline. Technik , then, is the technological quotient of civilization. It pledges $1.5 The contrast between the U.N.'s

First-mover Advantage 8

First-mover Advantage GDP Technology Biotechnology 8

Harvard Business Review

OCTOBER 23, 2014

It’s only recently, though, that advances in information technology have made it possible for predictive tools to access and manipulate big data, and to do so continuously — accelerating the generation of insights, and opening up opportunities to anticipate issues with unprecedented precision. Health Information & technology'

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

OCTOBER 22, 2013

In order to do this, your company needs a process to source radical ideas that can catapult your business to new heights, open up new markets, or bring in completely unfamiliar profit streams. Three major factors drive convergence: technology, competition, and the customer. Let’s say you’re in the energy sector. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. It is commonly believed that emerging market companies tap Western R&D talent in order to 'move up the value chain.'

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JULY 16, 2013

And 43% cited technology expertise, HR-talent management, international-global expertise, and succession planning as the skills missing most on their boards. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., We also looked at results by industry and region.

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

MARCH 5, 2012

Thus, the decline of manufacturing is not completely a result of "natural" market forces. Sure, with improvements in information technology and communication, some services are becoming more tradable and that creates opportunities for the U.S. To make up the difference, we just borrow. But let's not kid ourselves. The Right Policies.

Health Care 9

Health Care Biotechnology Industry Policies 9

Harvard Business Review

OCTOBER 16, 2013

Or Chipotle, $12 billion market value right now based in Denver. Under Armour, athletic-wear company based in Baltimore. Groupon in the social commerce space, based in Chicago. I think venture capitalists do play a role. They are fueling innovation and growth.

Venture Capitalist 10

Venture Capitalist Company Biotechnology Transportation 10

Harvard Business Review

MAY 15, 2015

Mary Shelley told us nothing about the future of biotechnology, but the popularity and plausibility of Frankenstein: The Modern Prometheus tells us a lot about 1818’s fears and aspirations for technology and its relation to society. What science fiction has always done brilliantly, though, is predict the present.

Class 8

Class Open-book Politics Biotechnology 8

Harvard Business Review

FEBRUARY 19, 2015

Or pay a freelance consultant to do market research? They “carved out time on nights and weekends” to do research and market analysis. ” Kate left her job at PerkinElmer in February 2014; the next month, she and her business partner started ORIGƷN, a Boston-based biotechnology company. Patch weak spots.

Project 8

Project Outsourcing Learning-by-Doing Commitment 8

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

NOVEMBER 9, 2016

While it’s understandable that stock and currency markets would react this way to the outcome of the election, I believe that it’s somewhat of an overreaction. The price of steel is set in international markets and is subject to high cyclical variations. president. Source ideas through foreign direct investment.

Cooper 14

Cooper Long-term Industry Health Care 14